Loading stock data…
Labcorp Holdings Inc. (LH)
$324.86-2.03 (-0.62%)
Market ClosedLast close Sep 8
Labcorp Holdings Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Labcorp Holdings Inc. in the Healthcare sector is trading at $324.86 with a market capitalization of $26.5B. Wall Street consensus targets $341.50 (16 analysts), implying a +5.1% move over the next 12 months. The stock is currently near its 52-week high of $341.80, remaining 18.3% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +5.1% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $3.54B↑ | $3.52B↓ | $3.56B↑ | $3.53B |
| Gross Profit | — | $1.01B↑ | $993.20M↓ | $1.03B↓ | $1.05B |
| Operating Income | — | $387.20M↑ | $382.00M↓ | $403.20M↑ | $398.60M |
| Net Income | — | $277.80M↑ | $164.70M↓ | $261.10M↑ | $237.90M |
Peer Comparison
JNJUNHPFE
Fundamentals
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$26.51B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
27.04
Beta
Defensive asset. Lower volatility than the S&P 500.
0.85
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.66%
ROE
Average efficiency. Growth may require heavy reinvestment.
11.65%
Volume
Today's trading volume
610,675
Recent News
New Study Reveals Strongest State Economies, Only 1 State Was Better Than Texas
CNBC's 20th annual state business rankings handed the overall crown to Ohio for the first time ever, but in the critical economy sub-category it was a two-state race: North Carolina led the nation and Texas came in second, even as the Lone Star State carries more foreign investment than any other top-10 economy in the country.
Market Shocks Are Not Where Hims & Hers Health Stock Has Fallen Furthest
Its deepest fall inside a market shock is not its deepest fall, and that gap is what a holder should size for.
Labcorp Holdings (LH) Unveiled The First FDA Cleared Single Biomarker Alzheimer’s Blood Test
Labcorp Holdings (NYSE: LH) introduced the Elecsys pTau-217 blood test, the first FDA-cleared single biomarker test for Alzheimer’s disease, expanding access through primary and specialty care. The Elecsys pTau-217 test is positioned to support clinical assessment of cognitive decline with a minimally invasive blood draw instead of more invasive procedures. Labcorp announced a long-term alliance with the National Association of Community Health Centers to support clinical leadership and...
Are Wall Street Analysts Bullish on Labcorp Holdings Stock?
Do Wall Street analysts favor Labcorp’s stock, given its solid performance?
3 Reasons LH is Risky and 1 Stock to Buy Instead
Over the past six months, Labcorp has been a great trade, beating the S&P 500 by 9.5%. Its stock price has climbed to $339.34, representing a healthy 20% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.